The pharmacist role in predicting and improving medication adherence in heart failure patients

Journal of Managed Care Pharmacy

Volumn 20, Issue 7, 2014, Pages 741-755

  Davis, Estella M ^a   Packard, Kathleen A ^a   Jackevicius, Cynthia A ^b  

^a CREIGHTON UNIVERSITY SCHOOL OF PHARMACY AND HEALTH PROFESSIONS   (United States)

^b WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

CLINICAL ASSESSMENT TOOL; CONSULTATION; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PHARMACEUTICAL CARE; PHARMACIST; REVIEW; AGED; ECONOMICS; HOSPITALIZATION; MORTALITY; ORGANIZATION AND MANAGEMENT; PHARMACY; PROFESSIONAL STANDARD; RISK; STATISTICS AND NUMERICAL DATA; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; HEALTH CARE COST; HOSPITAL COST; MERCK ADHERENCE ESTIMATOR; MORISKY MEDICATION ADHERENCE SCALE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; RISK ASSESSMENT; TREATMENT REFUSAL;

AGED; HEART FAILURE; HOSPITALIZATION; HUMANS; MEDICATION ADHERENCE; PHARMACEUTICAL SERVICES; PHARMACISTS; PROFESSIONAL ROLE; RISK;

EID: 84903216599     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2014.20.7.741     Document Type: Review

References (64)

1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics- 2013 update: a report from the American Heart Association. Circulation. 2013;127(1):e6-e245.
2. Centers for Medicare and Medicaid Services. Readmissions reduction program. Updated April 30, 2014. Available at: http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions- Reduction-Program.html. Accessed May 17, 2014.
3. Krumholz HM, Parent EM, Tu N, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med. 1997;157(1):99-104.
4. Curtis LH, Greiner MA, Hammill BG, et al. Early and long-term outcomes of heart failure in elderly persons, 2001-2005. Arch Intern Med. 2008;168(22):2481-88.
5. Annema C, Luttik ML, Jaarsma T. Reasons for readmission in heart failure: perspectives of patients, caregivers, cardiologists, and heart failure nurses. Heart Lung. 2009;38(5):427-34.
6. Ambardekar AV, Fonarow GC, Hernandez AF, Pan W, Yancy CW, Krantz MJ. Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from the Get With The Guidelines-Heart Failure (GWTG-HF). Am Heart J. 2009;158(4):644-52.
7. Wu JR, Moser DK, Lennie TA, Burkhart PV. Medication adherence in patients who have heart failure: a review of the literature. Nurs Clin North Am. 2008;43(1):133-53.
8. Hope CJ, Wu J, Tu W, Young J, Murray MD. Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure. Am J Health Syst Pharm. 2004;61(19):2043-49.
9. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521-30.
10. George J, Shalansky SJ. Predictors of refill non-adherence in patients with heart failure. Br J Clin Pharmacol. 2007;63(4):488-93.
11. Sun SX, Ye X, Lee KY, Dupclay L, Plauschinat C. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction. Clin Ther. 2008;30(Pt. 2):2217-27.
12. Mockler M, O'Loughlin C, Murphy N, et al. Causes and consequences of nonpersistence with heart failure medication. Am J Cardiol. 2009;103(6):834-38.
13. Murray MD, Tu W, Wu J, Morrow D, Smith F, Brater DC. Factors associated with exacerbation of heart failure include treatment adherence and health literacy skills. Clin Pharmacol Ther. 2009;85(6):651-58.
14. Lopert R, Shoemaker JS, Davidoff A, et al. Medication adherence and Medicare expenditure among beneficiaries with heart failure. Am J Manag Care. 2012;18(9):556-63.
15. Granger BB, Swedberg K, Ekman I, et al. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet. 2005;366(9502):2005-11.
16. Milfred-LaForest SK, Chow SL, DiDomenico RJ, et al. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. Pharmacotherapy. 2013;33(5):529-48.
17. Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med. 2008;168(7):687-94.
18. Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization; 2003.
19. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97.
20. Leventhal MJ, Riegel B, Carlson B, De Geest S. Negotiating compliance in heart failure: remaining issues and questions. Eur J Cardiovasc Nurs. 2005;4(4):298-307.
21. Calvin JE, Shanbhag S, Avery E, Kane J, Richardson D, Powell L. Adherence to evidence-based guidelines for heart failure in physicians and their patients: lessons from the Heart Failure Adherence Retention Trial (HART). Congest Heart Fail. 2012;18(2):73-78.
22. Granger BB, Ekman I, Granger CB, et al. Adherence to medication according to sex and age in the CHARM programme. Eur J Heart Fail. 2009;11(11):1092-98.
23. Setoguchi S, Choudhry NK, Levin R, Shrank WH, Winkelmayer WC. Temporal trends in adherence to cardiovascular medications in elderly patients after hospitalization for heart failure. Clin Pharmacol Ther. 2010;88(4):548-54.
24. Riegel B, Lee CS, Ratcliffe SJ, et al. Predictors of objectively measured medication nonadherence in adults with heart failure. Circ Heart Fail. 2012;5(4):430-36.
25. Riegel B, Moelter ST, Ratcliffe SJ, et al. Excessive daytime sleepiness is associated with poor medication adherence in adults with heart failure. J Card Fail. 2011;17(4):340-48.
26. Chui MA, Deer M, Bennett SJ, et al. Association between adherence to diuretic therapy and health care utilization in patients with heart failure. Pharmacotherapy. 2003;23(3):326-32.
27. Gislason GH, Rasmussen JN, Abildstrom SZ, et al. Persistent use of evidence- based pharmacotherapy in heart failure is associated with improved outcomes. Circulation. 2007;116(7):737-44.
28. Hansen RA, Dusetzina SB, Song L, Gaynes BN, Tu W, Murray MD. Depression affects adherence measurement but not the effectiveness of an adherence intervention in heart failure patients. J Am Pharm Assoc (2003). 2009;49(6):760-68.
29. Lamb DA, Eurich DT, McAlister FA, et al. Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003. Circ Cardiovasc Qual Outcomes. 2009;2(3):228-35.
30. Noureldin M, Plake KS, Morrow DG, Tu W, Wu J, Murray MD. Effect of health literacy on drug adherence in patients with heart failure. Pharmacotherapy. 2012;32(9):819-26.
31. Wu JR, Lennie TA, Chung ML, et al. Medication adherence mediates the relationship between marital status and cardiac event-free survival in patients with heart failure. Heart Lung. 2012;41(2):107-14.
32. Cole JA, Norman H, Weatherby LB, Walker AM. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes. Pharmacotherapy. 2006;26(8):1157-64.
33. Wu JR, Frazier SK, Rayens MK, Lennie TA, Chung ML, Moser DK. Medication adherence, social support, and event-free survival in patients with heart failure. Health Psychol. 2013;32(6):637-46.
34. Wu JR, Lennie TA, De Jong MJ, et al. Medication adherence is a mediator of the relationship between ethnicity and event-free survival in patients with heart failure. J Card Fail. 2010;16(2):142-49.
35. Canty-Mitchell J, Zimet GD. Psychometric properties of the Multidimensional Scale of Perceived Social Support in urban adolescents. Am J Community Psychol. 2000;28(3):391-400.
36. Sadik A, Yousif M, McElnay JC. Pharmaceutical care of patients with heart failure. Br J Clin Pharmacol. 2005;60(2):183-93.
37. López Cabezas C, Falces Salvador C, Cubí Quadrada D, et al. Randomized clinical trial of a postdischarge pharmaceutical care program vs. regular follow-up in patients with heart failure. Farm Hosp. 2006;30(6):328-42.
38. Bouvy ML, Heerdink ER, Urquhart J, Grobbee DE, Hoes AW, Leufkens HG. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail. 2003;9(5):404-11.
39. Murray MD, Young J, Hoke S, et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007;146(10):714-25.
40. Goodyer LI, Miskelly F, Milligan P. Does encouraging good compliance improve patients' clinical condition in heart failure? Br J Clin Pract. 1995;49(4):173-76.
41. Varma S, McElnay JC, Hughes CM, Pasmore AP, Varma M. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy. 1999;19(7):860-69.
42. Gwadry-Sridhar FH, Arnold JM, Zhang Y, Brown JE, Marchiori G, Guyatt G. Pilot study to determine the impact of a multidisciplinary educational intervention in patients hospitalized with heart failure. Am Heart J. 2005;150(4):982.
43. Tsuyuki RT, Fradette M, Johnson JA, et al. A multicenter disease management program for hospitalized patients with heart failure. J Card Fail. 2004;10(6):473-80.
44. Eggink RN, Lenderink AW, Widdershoven JW, van den Bemt PM. The effect of a clinical pharmacist discharge service on medication discrepancies in patients with heart failure. Pharm World Sci. 2010;32(6):759-66.
45. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med. 1999;159(16):1939-45.
46. Rainville EC. Impact of pharmacist interventions on hospital readmissions for heart failure. Am J Health Syst Pharm. 1999;56(13):1339-42.
47. Stewart S, Pearson S, Horowitz JD. Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. Arch Intern Med. 1998;158(10):1067-72.
48. Triller DM, Hamilton RA. Effect of pharmaceutical care services on outcomes for home care patients with heart failure. Am J Health Syst Pharm. 2007;64(21):2244-49.
49. Phillips CO, Wright SM, Kern DE, Singa RM, Shepperd S, Rubin HR. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. JAMA. 2004;291(11):1358-67.
50. Trindade AJ, Ehrlich A, Kornbluth A, Ullman TA. Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence. Inflamm Bowel Dis. 2011;17(2):599-604.
51. Evangelista LS, Berg J, Dracup K. Relationship between psychosocial variables and compliance in patients with heart failure. Heart Lung. 2001;30(4):294-301.
52. van der Wal MH, Jaarsma T, Moser DK, Veeger NJ, van Gilst WH, van Veldhuisen DJ. Compliance in heart failure patients: the importance of knowledge and beliefs. Eur Heart J. 2006;27(4):434-40.
53. Nieuwenhuis MM, Jaarsma T, van Veldhuisen DJ, van der Wal MH. Selfreported versus "true" adherence in heart failure patients: a study using the Medication Event Monitoring System. Neth Heart J. 2012;20(7-8):313-19.
54. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74.
55. Shalansky SJ, Levy AR, Ignaszewski AP. Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother. 2004;38(9):1363-68.
56. Krapek K, King K, Warren SS, et al. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother. 2004;38(9):1357-62.
57. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348-54.
58. McHorney CA. The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr Med Res Opin. 2009;25(1):215-38.
59. McHorney CA, Victor Spain C, Alexander CM, Simmons J. Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: a prospective analysis of data from pharmacy claims. Clin Ther. 2009;31(11):2584-607.
60. Gehi AK, Ali S, Na B, Whooley MA. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study. Arch Intern Med. 2007;167(16):1798-803.
61. Svarstad BL, Chewing BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37(2);113-24.
62. Hahn SR, Park J, Skinner EP, et al. Development of the ASK-20 adherence barrier survey. Curr Med Res Opin. 2008;24(7):2127-38.
63. Risser J, Jacobson TA, Kripalani S. Development and psychometric evaluation of the Self-Efficacy for Appropriate Medication Use Scale (SEAMS) in low-literacy patients with chronic disease. J Nurs Meas. 2007;15(3):203-19.
64. Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs. 2000;15(3):90-96.